Monocentric Prospectiv Observational Clinical Trial of Pelvic Floor Biometry During Pregnancy and Puerperium
Monocentric Prospectiv Observational Clinical Trial of Pelvic Floor Biometry During Pregnancy and Puerperium : Relationship with Symptoms Related to Post-partum Pelvic Floor Dysfunction
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Arsenio Spinillo
- Phone Number: +39382503267
- Email: spinillo@smatteo.pv.it
Study Locations
-
-
-
Pavia, Italy, 27100
- Recruiting
- Fondazione IRCCS Policlinico San Matteo, SC Ostetricia e Ginecologia 1
-
Contact:
- Arsenio Spinillo, MD
- Phone Number: +390382503267
- Email: spinillo@smatteo.pv.it
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- single pregnancy confirmed by ultrasound in the first trimester (within 10 weeks of gestational age),
- maternal age between 18 and 40 years,
- patients who speak Italian correctly and/or who can perfectly understand what was expressed at the time of enrollment.
- spontaneous vaginal births, operative and current cesarean section
- patients who do not report urinary and fecal incontinence or pelvic organ prolapse at enrollment.
Exclusion Criteria:
- previous pregnancy ended with spontaneous vaginal delivery or cesarean section
- pelvic floor reconstructive surgery
- gynecological cancer
- pelvic radiation therapy for previous oncological disease
- previous pelvic trauma
- known connective tissue disease
- body mass index >40 kg / m2.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
PREGNAANT WOMEN
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
pelvic floor biometry
Time Frame: baseline, at second trimester of pregnancy, at third trimester of pregnancy, six weeks after delivery
|
evaluate the association between the biometry of the pelvic floor and the presence of symptoms such as urinary and fecal incontience, pelvic weight and vaginal congestion typical of genital prolapse, related to pelvic-perineal dysfunction at the check-up carried out 6 months after delivery.
Specifically, the following end-points will be evaluated: pelvic hiatus area, measured in the last trimester of pregnancy and in the post-partum
|
baseline, at second trimester of pregnancy, at third trimester of pregnancy, six weeks after delivery
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
pelvic floor biometry
Time Frame: baseline, at second trimester of pregnancy, at third trimester of pregnancy, six weeks after delivery
|
|
baseline, at second trimester of pregnancy, at third trimester of pregnancy, six weeks after delivery
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
General Publications
- Solans-Domenech M, Sanchez E, Espuna-Pons M; Pelvic Floor Research Group (Grup de Recerca del Sol Pelvia; GRESP). Urinary and anal incontinence during pregnancy and postpartum: incidence, severity, and risk factors. Obstet Gynecol. 2010 Mar;115(3):618-628. doi: 10.1097/AOG.0b013e3181d04dff.
- Costantini S, Esposito F, Nadalini C, Lijoi D, Morano S, Lantieri P, Mistrangelo E. Ultrasound imaging of the female perineum: the effect of vaginal delivery on pelvic floor dynamics. Ultrasound Obstet Gynecol. 2006 Feb;27(2):183-7. doi: 10.1002/uog.2663.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- PavPel
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.